APA (7th ed.) Citation

Fleischmann, R., Connolly, S. E., Maldonado, M. A., & Schiff, M. (2016). Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab. Arthritis & rheumatology (Hoboken, N.J.), 68(9), 2083-2089. https://doi.org/10.1002/art.39714

Chicago Style (17th ed.) Citation

Fleischmann, Roy, Sean E. Connolly, Michael A. Maldonado, and Michael Schiff. "Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab." Arthritis & Rheumatology (Hoboken, N.J.) 68, no. 9 (2016): 2083-2089. https://doi.org/10.1002/art.39714.

MLA (9th ed.) Citation

Fleischmann, Roy, et al. "Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab." Arthritis & Rheumatology (Hoboken, N.J.), vol. 68, no. 9, 2016, pp. 2083-2089, https://doi.org/10.1002/art.39714.